Document and Entity Information
Document and Entity Information | Oct. 27, 2022 |
Cover [Abstract] | |
Entity Registrant Name | ACORDA THERAPEUTICS INC |
Amendment Flag | true |
Entity Central Index Key | 0001008848 |
Document Type | 8-K/A |
Document Period End Date | Oct. 27, 2022 |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-31938 |
Entity Tax Identification Number | 13-3831168 |
Entity Address, Address Line One | 2 Blue Hill Plaza |
Entity Address, Address Line Two | 3rd Floor |
Entity Address, City or Town | Pearl River |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 10965 |
City Area Code | (914) |
Local Phone Number | 347-4300 |
Written Communications | false |
Soliciting Material | true |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.001 par value per share |
Trading Symbol | ACOR |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Amendment Description | On October 27, 2022, Acorda Therapeutics, Inc. (the “Company”) filed a Current Report on Form 8-K to announce, among other things, its long-term business plan (the “Original 8-K”). This amendment is being filed by the Company solely for the purpose of updating the Original 8-K as further described below. |